Predictors of Willingness to Enroll in Hypothetical Alzheimer Disease Biomarker Studies that Disclose Personal Results

Alzheimer Dis Assoc Disord. 2022 Apr-Jun;36(2):125-132. doi: 10.1097/WAD.0000000000000490. Epub 2022 Feb 4.

Abstract

Introduction: We examined factors related to willingness to enroll in hypothetical Alzheimer disease (AD) biomarker studies.

Methods: Using linear regression, we assessed the relationship among enrollment willingness and demographics, family dementia history, research attitudes, concern about AD, experiences of discrimination, and belief in AD risk modifiability. Inductive coding was used to assess qualitative data.

Results: In middle-aged and older adult AD research participants (n=334), willingness to enroll in biomarker studies was driven by biomarker collection method, research attitudes, and disclosure of personal results. Predictors of willingness were similar for Black and White participants. Themes associated with increased willingness included a desire to learn biomarker results and support research.

Discussion: Research attitudes were an important predictor of biomarker study willingness regardless of race. As seen elsewhere, Black participants were more hesitant to participate in biomarker research. Disclosure of biomarker results/risk can bolster willingness to enroll in biomarker studies, particularly for Black participants.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural

MeSH terms

  • Aged
  • Alzheimer Disease* / diagnosis
  • Attitude
  • Biomarkers
  • Disclosure
  • Humans
  • Middle Aged

Substances

  • Biomarkers